Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00025675What this trial is testingGefitinib in Treating Patients With Recurrent or Progressive CNS TumorsWho this might be right forBrain and Central Nervous System Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 105
Not applicableWithdrawnNCT00005790What this trial is testingPerfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain TumorsWho this might be right forBrain and Central Nervous System Tumors Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00014573What this trial is testingChemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain CancerWho this might be right forBrain and Central Nervous System Tumors Barbara Ann Karmanos Cancer Institute
Not applicableWithdrawnNCT02194452What this trial is testingEfficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain TumorsWho this might be right forAcoustic SchwannomaAdult Anaplastic AstrocytomaAdult Anaplastic Ependymoma+92 more Sue O'Dorisio
Testing effectiveness (Phase 2)Ended earlyNCT00003292What this trial is testingS9624 Ifosfamide in Treating Patients With Meningeal TumorsWho this might be right forChondrosarcomaAdult FibrosarcomaAdult Leiomyosarcoma+3 more SWOG Cancer Research Network 7
Not applicableStudy completedNCT00499798What this trial is testingChanges in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain TumorsWho this might be right forBrain and Central Nervous System TumorsChemotherapeutic Agent ToxicityInfertility Wake Forest University Health Sciences 16
Not applicableStudy completedNCT00967200What this trial is testingStudy of Tissue Samples From Patients With Glioma or Other Brain TumorsWho this might be right forCentral Nervous System Lymphoma University Hospital, Montpellier 180
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Early research (Phase 1)Study completedNCT01082926What this trial is testingPhase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2Who this might be right forAnaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Meningioma+11 more City of Hope Medical Center 6